Drug Development
Positive Aggrastat injection strategy trial data published
Published in Drug Week, June 10th, 2005
The study found that a combination of Aggrastat and a drug-eluting stent (DES; sirolimus eluting stent) resulted in a significantly lower rate of death, myocardial infarction, stroke, and binary restenosis at 8 months for patients with ST-elevation myocardial infarction (STEMI), while also providing a similar cost of care when compared to abciximab used in combination with a bare metal stent.
Marco...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-06-10)
More Articles from Drug Week
- Cancer Therapy
Phase II trial of AP23573 initiated in hormone-refractory prostate cancer - Drug Development
U.S. FDA grants approval of Byetta (exenatide) injection for diabetes - Psoriasis Therapy
Overview of biologic agents in medicine and dermatology presented - Tuberculosis
Data: FAS20013 demonstrates killing effect against TB - Acute Bacterial Conjunctivitis
Gatifloxacin 0.3% BID safe and effective in clinical trial - Acute Lymphoblastic Leukemia
Company initiates phase I/II clinical trial of talotrexin in patients with ALL - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
